Foglio illustrativo: informazioni per l'utilizzatore Beclometasone Teva 400 microgrammi Sospensione per nebulizzatore Beclomet
![Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml](https://www.docpeter.it/media/catalog/product/p/r/prontinal_800_mcg_sospensione_per_nebulizzatore_0_8_mg_2_ml_sospensione_da_n_032798023.jpg)
Prontinal 800 mcg sospensione per nebulizzatore - 0,8 mg/2 ml sospensione da nebulizzare 20 contenitori monodose 2 ml
![PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids](https://i1.rgstatic.net/publication/311554036_High_strength_extrafine_pMDI_beclometasoneformoterol_2006_mg_is_effective_in_asthma_patients_not_adequately_controlled_on_medium-high_dose_of_inhaled_corticosteroids/links/584c03e808aeb989251f23d6/largepreview.png)
PDF) High strength extrafine pMDI beclometasone/formoterol (200/6 μg) is effective in asthma patients not adequately controlled on medium-high dose of inhaled corticosteroids
RIASSUNTO DELLE CARATTERISTICHE DEL PRODOTTO 1. DENOMINAZIONE DEL MEDICINALE Beclometasone Teva 400 microgrammi sospensione per
![PDF) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone PDF) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone](https://i1.rgstatic.net/publication/358598316_Interclass_Difference_in_Pneumonia_Risk_in_COPD_Patients_Initiating_Fixed_Dose_Inhaled_Treatment_Containing_Extrafine_Particle_Beclometasone_versus_Fine_Particle_Fluticasone/links/620cb968c5934228f96f7c0d/largepreview.png)
PDF) Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone
![Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids - The Journal of Allergy and Clinical Immunology: In Practice Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids - The Journal of Allergy and Clinical Immunology: In Practice](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/711261b3-f522-47c7-b8df-facab76d72c9/gr1_lrg.jpg)
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled Corticosteroids - The Journal of Allergy and Clinical Immunology: In Practice
![A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory A phase III study of triple therapy with budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler 320/18/9.6 μg and 160/18/9.6 μg using co-suspension delivery technology in moderate-to-very severe COPD: The ETHOS study protocol - Respiratory](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e94385f0-8043-48e8-b744-a3c1441be519/gr2_lrg.jpg)